Recently added

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

Ong, Michael; Rodriguez-Ruiz, Maria E; Machiels, Jean-Pascal; Sanmamed, Miguel F.; Gambardella, Valentina; Galvao, Vladimir (American Association for Cancer Research, 2025-03)

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Eigentler, Thomas; Thomas, Ioannis; Samoylenko, Igor; Erdmann, Michael; Leonhardt, Anna; Ochsenreither, Sebastian; Oberoi, Arjun (BMJ, 2025-02)

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

Lo Prinzi, Federica; salani, francesca; rimini, margherita; Rizzato, Mario Domenico; Antonuzzo, Lorenzo; Camera, Silvia; Castet, Florian (Oxford University Press, 2025-03)

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Hastie, Kathryn; Li, Zhe; Ke, Zunlong; Halfmann, Peter; DeWald, Lisa Evans; McArdle, Sara; Grinyo i Escuer, Ariadna (Nature Portfolio, 2025-02-03)

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project

Groen - van Schooten, Tessa Suzanne; Martinez Ciarpaglini, Carolina; Castillo, Ester; Ruiz-Garcia, Erika; Alsina, Maria; Ruiz Pace, Fiorella; Vivancos, Ana; Matito, Judit; Martin Casado, Agatha; Gómez-Rey, Marina; Vila-Casadesús, Maria; Díez García, Marc; Dienstmann, Rodrigo (Elsevier, 2025-03)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors ﻿

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma ﻿

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population ﻿

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane ﻿

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project ﻿

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP(1,2) in a position elevated from the virion membrane

Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project